ARYx Therapeutics, Inc. (NASDAQ: ARYX) 54.9% LOWER; getting slammed in pre-open trading after announcing that a trial of anticoagulant agent tecarfarin did not achieve the primary endpoint of superiority over leading oral anticoagulant warfarin. Click here for the full report.
Targacept, Inc. (Nasdaq: TRGT) 43.4% HIGHER; announced that AstraZeneca (NYSE: AZN) has informed Targacept that it plans to conduct further development of AZD3480 (TC-1734) for attention deficit/hyperactivity disorder and has agreed to make a $10 million milestone payment to...
Post new comment